Medical and microbiology records of seventeen patients (17 eyes), diagnosed as scleritis of infectious origin were reviewed; to study clinical features, predisposing risk factors, microbiologic profile and treatment outcome of infectious scleritis. The mean patient age was years. Twelve patients (70.6%) had history of trauma/prior surgery. Isolated organisms included Staphylococcus species (spp) , Fungus , Nocardia spp , two each of atypical Mycobacterium spp and Streptococcus pneumoniae and one Pseudomonas aeruginosa. Treatment included intensive topical antimicrobial in all eyes and systemic medication in 15？(88.2%) patients; surgical exploration was needed for 13？(76.5%) patients and scleral patch graft was done in four (23.5%) patients. Lesions resolved in all patients and none required evisceration. The presenting log MAR visual acuity of and improved to . after treatment with a mean follow up of weeks. A microbiological confirmation, appropriate medical and/or surgical intervention has a good tectonic and visual outcome. 1. Introduction Infectious scleritis presents as an ulcerated or nonulcerated, inflamed scleral nodule [1]. It accounts for 5–10% of all cases of scleritis [2–5]. But the presenting picture of infectious scleritis may not differ too much from immune-mediated scleritis [6–10]. Approximately 40–90% of immune mediated scleritis have an associated systemic vascular disease [3, 4, 6, 10]. While systemic treatment with corticosteroids or immunosuppressant benefits immune-mediated scleritis, it worsens the infectious scleritis. Hence it is imperative to differentiate between two conditions. Many authors have reported infection by Pseudomonas aeruginosa and fungus as the most common causative organism [1, 11–13]. Pterygium surgery with beta radiation or application of mitomycin C has been identified as a common risk factor for infectious scleritis [11–13]. The clinical outcome is generally poor and most cases required evisceration in the many series [8, 9, 14]. Systemic and topical medication combined with early surgical intervention have improved the anatomical success, but not the visual outcome in two other series [1, 12]. Infectious scleritis is a rare entity; hence it is not suspected at the initial presentation resulting in delayed diagnosis and treatment. In this communication, we describe the predisposing factors, clinical features, etiology, and treatment outcome of infectious scleritis. 2. Material and Method We retrospectively reviewed the medical and microbiological records of all patients with microbiologically proven
References
[1]
V. Jain, P. Garg, and S. Sharma, “Microbial scleritis—experience from a developing country,” Eye, vol. 23, no. 2, pp. 255–261, 2009.
[2]
D. A. Jabs, A. Mudun, J. P. Dunn, and M. J. Marsh, “Episcleritis and scleritis: clinical features and treatment results,” American Journal of Ophthalmology, vol. 130, no. 4, pp. 469–476, 2000.
[3]
M. S. de la Maza, N. S. Jabbur, and C. S. Foster, “Severity of scleritis and episcleritis,” Ophthalmology, vol. 101, no. 2, pp. 389–396, 1994.
[4]
E. K. Akpek, J. E. Thorne, F. A. Qazi, D. V. Do, and D. A. Jabs, “Evaluation of patients with scleritis for systemic disease,” Ophthalmology, vol. 111, no. 3, pp. 501–506, 2004.
[5]
T. A. Albini, N. A. Rao, and R. E. Smith, “The diagnosis and management of anterior scleritis,” International Ophthalmology Clinics, vol. 45, no. 2, pp. 191–204, 2005.
[6]
N. Okhravi, B. Odufuwa, P. McCluskey, and S. Lightman, “Scleritis,” Survey of Ophthalmology, vol. 50, no. 4, pp. 351–363, 2005.
[7]
W. P. Riono, A. A. Hidayat, and N. A. Rao, “Scleritis: a clinicopathologic study of 55 cases,” Ophthalmology, vol. 106, no. 7, pp. 1328–1333, 1999.
[8]
M. S. de la Maza, R. K. Hemady, and C. S. Foster, “Infectious scleritis: report of four cases,” Documenta Ophthalmologica, vol. 83, no. 1, pp. 33–41, 1993.
[9]
D. Sevel, “Necrogranulomatous scleritis. Clinical and histologic features,” American Journal of Ophthalmology, vol. 64, no. 6, pp. 1125–1134, 1967.
[10]
C. Y. Su, J. J. Tsai, Y. C. Chang, and C. P. Lin, “Immunologic and clinical manifestations of infectious scleritis after pterygium excision,” Cornea, vol. 25, no. 6, pp. 663–666, 2006.
[11]
F. C. Huang, S. P. Huang, and S. H. Tseng, “Management of infectious scleritis after pterygium excision,” Cornea, vol. 19, no. 1, pp. 34–39, 2000.
[12]
C. H. Hsiao, J. J. Chen, S. C. Huang, H. K. Ma, P. Y. Chen, and R. J. Tsai, “Intrascleral dissemination of infectious scleritis following pterygium excision,” British Journal of Ophthalmology, vol. 82, no. 1, pp. 29–34, 1998.
[13]
C. P. Lin, M. H. Shih, and M. C. Tsai, “Clinical experiences of infectious scleral ulceration: a complication of pterygium operation,” British Journal of Ophthalmology, vol. 81, no. 11, pp. 980–983, 1997.
[14]
M. G. Reynolds and E. Alfonso, “Treatment of infectious scleritis and keratoscleritis,” American Journal of Ophthalmology, vol. 112, no. 5, pp. 543–547, 1991.
[15]
D. D. O. Machado, A. L. L. Curi, R. S. Fernandes, T. F. Bessa, W. R. Campos, and F. Oréfice, “Scleritis: clinical characteristics, systemic associations, treatment and outcome in 100 patients,” Arquivos Brasileiros de Oftalmologia, vol. 72, no. 2, pp. 231–235, 2009.
[16]
K. B. Ebrahimi, W. R. Green, R. Grebe, and A. S. Jun, “Acanthamoeba sclerokeratitis,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 2, pp. 283–286, 2009.
[17]
O. Oz, D. H. Lee, S. M. Smetana, and L. Akduman, “A case of infected scleral buckle with Mycobacterium chelonae associated with chronic intraocular inflammation,” Ocular Immunology and Inflammation, vol. 12, no. 1, pp. 65–67, 2004.
[18]
E. Tay, M. Rajan, and S. Tuft, “Listeria monocytogenes sclerokeratitis: a case report and literature review,” Cornea, vol. 27, no. 8, pp. 947–949, 2008.
[19]
U. Gopinathan, P. Garg, M. Fernandes, S. Sharma, S. Athmanathan, and G. N. Rao, “The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India,” Cornea, vol. 21, no. 6, pp. 555–559, 2002.
[20]
W. Bernauer, B. D. S. Allan, and J. K. G. Dart, “Successful management of Aspergillus scleritis by medical and surgical treatment,” Eye, vol. 12, part 2, pp. 311–316, 1998.
[21]
C. J. Helm, G. N. Holland, R. G. Webster Jr., R. K. Maloney, and B. J. Mondino, “Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis,” Ophthalmology, vol. 104, no. 5, pp. 838–843, 1997.
[22]
I. M. Raber, P. R. Laibson, G. H. Kurz, and V. B. Bernardino, “Pseudomonas corneoscleral ulcers,” American Journal of Ophthalmology, vol. 92, no. 3, pp. 353–362, 1981.
